- Home
- SYRE vs CROX Comparison
SYRE vs CROX Comparison
Compare SYRE & CROX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SYRE | CROX |
|---|---|---|
| Founded | 2013 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.1B |
| IPO Year | 2015 | 2005 |
Fundamental Metrics
Financial Performance| Metric | SYRE | CROX |
|---|---|---|
| Price | $71.71 | $103.33 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 12 |
| Target Price | $85.08 | ★ $99.90 |
| AVG Volume (30 Days) | 1.3M | ★ 1.3M |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.71 |
| Revenue | N/A | ★ $4,040,647,000.00 |
| Revenue This Year | N/A | $2.01 |
| Revenue Next Year | N/A | $2.60 |
| P/E Ratio | ★ N/A | $37.31 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.29 | $73.21 |
| 52 Week High | $76.00 | $116.11 |
Technical Indicators
Market Signals| Indicator | SYRE | CROX |
|---|---|---|
| Relative Strength Index (RSI) | 62.72 | 58.53 |
| Support Level | $30.39 | $74.96 |
| Resistance Level | $74.92 | $113.16 |
| Average True Range (ATR) | 4.18 | 3.95 |
| MACD | -0.78 | -0.78 |
| Stochastic Oscillator | 43.70 | 41.19 |
Price Performance
Historical ComparisonAbout SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About CROX Crocs Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable operating segments of the company are the Crocs Brand and the HEYDUDE Brand. The company derives maximum revenue from the Crocs brand segment.